HAL (France)
open access
Activated clotting time in cardiac surgery, cardiological interventional procedures, vascular surgery, extracorporeal membrane oxygenation, and haemodialysis
The activated clotting time (ACT) is a point-of-care test used to monitor unfractionated heparin (UFH) in acute care settings. Although widely recommended in cardiac surgery, interventional cardiology, vascular surgery, extracorporeal membrane oxygenation, and haemodialysis, important uncertainties
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac Surgery#1173407
- Platelet Activity in Vascular Surgery for Thrombosis and Bleeding#1044672
- Intravascular Clotting (POCUS) - Marker of the Timing and Severity of Cardiac Arrest; Indicator of Futile Resuscitation#1321546
- Active Clearance Technology (ACT) II German Multicenter Trial#1395142
- Goal-orientated Coagulation Management in Hypothermic Cardiac Arrest Surgery#1211409
Record · ID 1537592
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive